Have you heard about Xeomin, the latest wrinkle reducing injectable available now at Atagi Plastic Surgery and Atagi Skin Aesthetics? For years, Xeomin has been used successfully in Europe to treat frown lines, crow’s feet, vertical lip lines, and other facial wrinkles. It is now FDA approved in the United States as a wrinkle reducing injectable and available in Denver for use at Atagi Plastic Surgery and Atagi Skin Aesthetics.
Xeomin can provide the smoother, more youthful-looking skin that Botox® users have enjoyed for years. However, Xeomin offers some additional benefits that board-certified Plastic Surgeon, Dr. Tanya Atagi is enthused about.
Xeomin is additive-free, so the body does not develop the antibodies that can reduce the effectiveness and longevity of Botox over time. Not only will the body continue to respond to Xeomin time after time, studies suggest that the results from Xeomin are longer lasting in some patients. Although variable from patient to patient, some find Xeomin to be faster acting than Botox.
Like Botox, Xeomin shares the same active protein as Botox working to block the signals from the nerves to the muscles that trigger muscle contraction. This in turn results in wrinkle reduction and a smoother, more youthful appearance. Both can be used to help elevate and arch the brows, smooth and soften the crow’s feet around the eyes, and reduce frown lines, to name only a few applications.
Ready to learn more about Xeomin at Atagi Plastic Surgery and Atagi Skin Aesthetics? Call us at (303) 327-7300 or email email@example.com.